Contact
QR code for the current URL

Story Box-ID: 249594

Hummingbird Diagnostics GmbH Im Neuenheimer Feld 519 69120 Heidelberg, Germany http://www.hummingbird-diagnostics.com
Contact Ms Eva Sterzel +49 6221 6510300
Company logo of Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH

Webinar: The Power to Detect: HybSelect for Targeted Sequence Capture

Presenter: Jack T. Leonard, Ph.D., Vice President of Technology Commercialization, febit inc., Lexington, MA (USA)

(PresseBox) (Heidelberg, )
The proliferation of Next-Gen Sequencing (NGS) platforms has increased DNA sequencing throughput by orders of magnitude, however, it still takes months and several hundreds of thousands of dollars to finish a typical mammalian-sized genome at a reasonable depth of coverage. Certain "high value" regions of the genome have been associated with certain disease states, phenotypic traits, or responses to drug treatment or other environmental stimuli. Targeted re-sequencing of genomes can identify variants faster and at a much lower cost than whole genome sequencing.

Genomic hot-spots ranging between tens and thousands of kilobases are excellent targets for HybSelect, a new automated microfluidic solution for sequence-specific capture from febit. Integrated HybSelect automation allows walk-away convenience and only requires 30 minutes of hands-on time, offering the simplest targeted sequence capture method available. In this webinar, we will describe the HybSelect workflow and typical results where one thousand 500 bp regions with a centrally located SNP were captured from a reference sample. After NGS, the average depth of coverage for the individual 500 bp regions was 469-fold. 91.2% of the 1000 SNP positions were covered at ?20x, and 99% of those were concordant with the reference sequence as is consistent with baseline Illumina NGS SNP calling accuracy. Importantly, 98.1% of the heterozygous SNP positions were detected and called correctly with no evidence of allelic bias. We will also describe the results with our new catalogue 2 Mb Cancer Exon Biochip, and share our anticipated improvements for HybSelect over the next 12 months, including expanding the capacity to 30 Mb per array, sufficient to capture eight human exome equivalents per Biochip at high depth of coverage.

Wednesday, March 25, 2009
11:00 a.m. EDT / 4:00 p.m. CET
Webinar Log-in: www.febit.com
Contact: webinar@febit.com
The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2024, All rights reserved

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.